Nicole Sweeny is Chief Commercial Officer of Praxis Precision Medicines, Inc.. Currently has a direct ownership of 38,619 shares of PRAX, which is worth approximately $2.7 Million. The most recent transaction as insider was on Feb 12, 2023, when has been sold 1,456 shares (Common Stock) at a price of $3.94 per share, resulting in proceeds of $5,736. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.6K
0% 3M change
0% 12M change
Total Value Held $2.7 Million

Nicole Sweeny Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 12 2023
SELL
Payment of exercise price or tax liability
$5,736 $3.94 p/Share
1,456 Reduced 3.63%
38,619 Common Stock
Jan 07 2023
SELL
Payment of exercise price or tax liability
$5,239 $2.52 p/Share
2,079 Reduced 4.93%
40,075 Common Stock
May 13 2022
BUY
Grant, award, or other acquisition
$22,766 $8.8 p/Share
2,587 Added 5.78%
42,154 Common Stock
Feb 12 2022
SELL
Payment of exercise price or tax liability
$15,844 $12.85 p/Share
1,233 Reduced 3.02%
39,567 Common Stock
Jan 07 2022
BUY
Grant, award, or other acquisition
-
24,000 Added 37.04%
40,800 Common Stock
Feb 12 2021
BUY
Grant, award, or other acquisition
-
16,800 Added 50.0%
16,800 Common Stock
NS

Nicole Sweeny

Chief Commercial Officer
Cambridge, MA

Track Institutional and Insider Activities on PRAX

Follow Praxis Precision Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRAX shares.

Notify only if

Insider Trading

Get notified when an Praxis Precision Medicines, Inc. insider buys or sells PRAX shares.

Notify only if

News

Receive news related to Praxis Precision Medicines, Inc.

Track Activities on PRAX